Big pharma is driving progress in the major causes of death around the world. The following drugs created by their respective companies reflect the most promising medical breakthroughs that will impact patients in the coming year.
10. Cyramza by Eli Lilly and Company
Eli Lilly and Company’s (NYSE: LLY) drug Cyramza was recently approved by the FDA as a treatment for people with advanced or metastatic gastric (stomach) cancer. The approval of this combination regimen is for patients whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy. Stomach cancer is the fifth most common cancer in the world and is the third-leading cause of cancer death.
Comments
Post a Comment